The Instituto Nacional de Cancerología is a public institution administered by the Mexican Secretariat of Health which specializes in the treatment of cancer. It is one of 12 specialized hospitals that provides public health services and trains new resident doctors.

During the past decade, National Cancer Institute of Mexico conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute of Mexico" #1 collaborator was "Kimberly-Clark de México" with 1 trials as a collaborator, "Psicofarma S.A. de C.V." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Institute of Mexico" are "Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials), "Dysgeusia" (1 trials) and "EGFR" (1 trials). Many other conditions were trialed in "National Cancer Institute of Mexico" in a lesser frequency.

Most popular intervention types in "National Cancer Institute of Mexico" are "Drug" (4 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "2-octyl cyanoacrylate [InteguSEAL®]" (1 trials), "BIBW 2992" (1 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Hydralazine/Magnesium" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Institute of Mexico" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Institute of Mexico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Cancer Institute of Mexico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Institute of Mexico, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".